A clinical performance evaluation study with an IVD product as Investagional Use product - Clinical Monitor requirements

SANE

Starting to get Involved
Dear all, I hope you can help me.
There are documentations describing the requirements in respect to studies needed to collect data for a FDA submission. Usually drugs or a medical devices are described there as the product for investigational use.

Now we want to perform a non interventional pivotal study (just pivotal observational study) with an IVD laboratory diagnostic product labelled as product for investigational use only. We have several study sites (clinical centres) in Germany, one site in US will complete the German ones.

We have got different feedbacks related to the need of a "Clinical Monitor" for our study project. In general it is clear that a Clinical Monitor is needed if the investigational product is a medical device. However, there were different opinions related to the need of a Clinical Monitor for a study if the investigational product is an IVD product used in the lab (ELISA).

I do not find any proper documentation. Can somebody tell me whether a "Clinical Monitor" is needed? Can somebody tell me where I can find relevant documentation addressing this aspect.

Many thanks in advance for your support.
 

chris1price

Trusted Information Resource
Very difficult to answer without a lot more information. When I previously filed ELISA based laboratory IVDs, we did not use a clinical monitor, but that doesn't mean the same applies to your product. Filing a Q-Sub with FDA might be the best way to get an answer.
 

SANE

Starting to get Involved
Dear Chris1price,
thanks for the hint. Issue is that we have to decide for internal reason before going into the Q Sub. Did you use your study for FDA submission?
 

chris1price

Trusted Information Resource
Standard practice was to have blood samples collected from the appropriate demographics in the USA and have them tested at an independent lab. This was submitted to FDA as part of the 510(k)s. The only issues we saw concerned having sufficient data on the samples to ensure we met the necessary population demographics.
 

SANE

Starting to get Involved
Standard practice was to have blood samples collected from the appropriate demographics in the USA and have them tested at an independent lab. This was submitted to FDA as part of the 510(k)s. The only issues we saw concerned having sufficient data on the samples to ensure we met the necessary population demographics.
Ok. I think this we have considered. To be on the sure side we will cross check this with FDA as well.
 
Thread starter Similar threads Forum Replies Date
C How frequent to conduct Clinical / Performance Evaluation? CE Marking (Conformité Européene) / CB Scheme 4
A Do clinical performance studies for IVDs need to be conducted in a member state? EU Medical Device Regulations 2
A Do clinical performance studies for IVDs need to be conducted in a member state? CE Marking (Conformité Européene) / CB Scheme 0
N Pre-Clinical Performance Testing Design and Development of Products and Processes 3
S Summary of safety and clinical performance and Article 120(3) of the MDR EU Medical Device Regulations 4
M Informational MDCG 2019-9 Summary of safety and clinical performance A guide for manufacturers and notified bodies – August 2019 Medical Device and FDA Regulations and Standards News 1
D Summary of safety and clinical performance in GSPR MDR EU Medical Device Regulations 4
M Informational USFDA final guidance – Recommended Content and Format of Non-Clinical Bench Performance Testing Information in Premarket Submissions Medical Device and FDA Regulations and Standards News 0
A Summary of safety and clinical performance (SSCP) EU Medical Device Regulations 1
FoGia MEDDEV 2.7/1 rev 4 - Clinical Performance & Clinical Safety Claims EU Medical Device Regulations 3
S New GHTF guidance document on Clinical Studies Performance for IVDs Other Medical Device Regulations World-Wide 1
M Medical Device Website Document Control - Clinical Advice or Performance Claims Document Control Systems, Procedures, Forms and Templates 2
P EN 62304 Safety Class of an ECG device designed to be used in clinical situations when patient is in immediate danger. IEC 62304 - Medical Device Software Life Cycle Processes 3
H GSPR #1 - Clinical benefit/effectiveness lower than SoTA EU Medical Device Regulations 3
G Post market surveillance (PMCF) clinical investigation EU Medical Device Regulations 0
M Q: In what circumstances can a clinical investigator submit an EFS/IDE for the Significant Risk Device? US Medical Device Regulations 1
Ed Panek Use of Investigational Device i n Phase 1 Clinical Trial in EU EU Medical Device Regulations 1
G Post-Market Clinical Follow-Up (PMCF) studies EU Medical Device Regulations 0
T Clinical Study Design for IVD Self-Test (lay user) Products UK Medical Device Regulations 0
J US based company no longer selling in the EU: Clinical Evaluation Report and PMS requirements EU Medical Device Regulations 1
D MDR literature review on device without clinical claims EU Medical Device Regulations 7
A Clinical Evaluation Report Between Class I and Class IIa CE Marking (Conformité Européene) / CB Scheme 2
M Clinical evaluation process of FDA and MDR Medical Device and FDA Regulations and Standards News 2
S Clinical investigation outside the EU EU Medical Device Regulations 0
B Clinical evaluation according to equivalence with another device EU Medical Device Regulations 4
N Unused proceses (Clinical Evaluation) ISO 13485:2016 - Medical Device Quality Management Systems 4
M An introductory guide to medical device Clinical Evaluation & Clinical Evaluation Reports (CER) EU Medical Device Regulations 0
H MDR clinical evaluation EU Medical Device Regulations 0
I Brazil clinical data/trial requirement Other Medical Device Regulations World-Wide 1
Soog1459 Impact to clinical evaluation of MDCG2022-14 EU Medical Device Regulations 2
R Clinical evaluation for instrument of a navigation system EU Medical Device Regulations 1
I Clinical study suppliers (service providers) -- extent of control ISO 13485:2016 - Medical Device Quality Management Systems 4
A Loss of certification because of outdated information in the Clinical Evaluation Report CE Marking (Conformité Européene) / CB Scheme 8
C Clinical Trial using Prototype devices (EU MDR & ISO 14155) EU Medical Device Regulations 4
R MDR Clinical Evaluation Plan EU Medical Device Regulations 6
R Clinical Evaluation - state of the art literature search EU Medical Device Regulations 5
J Clinical Evaluation For Instruments - Class I, Class Ir, Class Im, and Class IIa - EU MDR EU Medical Device Regulations 4
M Clinical evaluation interface with the risk management process EU Medical Device Regulations 9
A Metadata For Drugs, API's, Regulatory & Clinical Documents and Dossier Service Industry Specific Topics 2
M Conducting a clinical investigation with clinical data from India EU Medical Device Regulations 3
V MDR – Article 65 – Clinical investigations on minors EU Medical Device Regulations 6
L Clinical Evaluation MDR EU Medical Device Regulations 15
B Clinical Investigation in Denmark for MDR EU Medical Device Regulations 2
F Using non-randomized clinical study for change in existing 510(k) device? US Food and Drug Administration (FDA) 1
S Exclusion of chapter 7.5 production for clinical investigation ISO 13485:2016 - Medical Device Quality Management Systems 1
K Clinical Studies of MD and IVD in the US US Food and Drug Administration (FDA) 6
A Post-market Clinical Follow-up Other Medical Device Related Standards 3
S IDCB 0129/0160 Clinical Risk Management ISO 14971 - Medical Device Risk Management 2
L Clinical investigation Medical Device and FDA Regulations and Standards News 0
I Clinical evaluation for legacy device EU Medical Device Regulations 16

Similar threads

Top Bottom